Nitric oxide inhibits cell growth in cultured human thyrocytes

Area of Science:

• Endocrinology
• Immunology
• Cell Biology

Background:

• Interleukin-1 (IL-1) and interferon-gamma (IFN-gamma) are cytokines known to modulate thyroid cell function.
• Nitric oxide (NO) is a signaling molecule with diverse roles in cellular processes.
• The specific effects of cytokine-induced NO on human thyrocyte proliferation require elucidation.

Purpose of the Study:

• To investigate the effect of IL-1 and IL-1/IFN-gamma-induced nitric oxide (NO) on human thyrocyte cell growth.
• To determine the role of cyclic GMP (cGMP) in NO-mediated thyrocyte growth inhibition.
• To elucidate the mechanism by which NO affects human thyrocyte proliferation.

Main Methods:

• Primary cultures of human thyrocytes were used.
• Nitric oxide (NO) production was induced by IL-1 or IL-1/IFN-gamma.
• Cell growth was assessed by bromo-deoxyuridine (Br-dU) incorporation.
• NO synthesis was inhibited using NG-monomethyl-L-arginine (L-MMA).
• Effects of a NO donor (S-nitroso-N-acetyl-penicillamine) and a cGMP analog (8-bromo-cGMP) were evaluated.

Main Results:

• Cytokine treatment led to increased NO production and cGMP formation, accompanied by inhibited cell growth.
• Blocking NO synthesis with L-MMA prevented cGMP formation and restored cell growth.
• A NO donor inhibited cell growth in a dose-dependent manner.
• A cell-permeable cGMP analog did not inhibit cell growth.

Conclusions:

• Endogenous NO produced by cytokine treatment inhibits human thyrocyte growth.
• Exogenous NO also exerts an inhibitory effect on human thyrocyte proliferation.
• The growth-inhibitory action of NO on human thyrocytes is independent of cyclic GMP (cGMP) signaling.